Early Phase Research - Autoimmune
Case Study: Delivering an Early-Phase Autoimmune Trial Across Regions
|
has not third author: true, (SizeLimitingPyMap: {main={}, second={}, third={}})
Custom Clinical Kitting Services
For Complex and Precision Medicine Trials
Integrating biomarker strategies with clinical operations to ensure sample integrity and regulatory compliance
In early-phase precision medicine trials, every sample holds significant value. Precision for Medicine specializes in bespoke kitting solutions that not only ensure accurate sample collection but also uphold the highest standards of regulatory compliance. Our blend of automation and human expertise allows us to adapt swiftly to the evolving needs of your trial, ensuring that your research progresses seamlessly.
Precision's newly updated facilities in Frederick, Maryland and Berlin, Germany provide global coverage, offering a reliable kitting partner with an approach designed to fit the specific needs of early-phase clinical trial kitting projects.
Key Differentiators
-
Adaptive Kitting Strategies
Tailored to meet the specific requirements of early-phase precision medicine trials. -
Regulatory Compliance
Ensuring that all processes align with the latest industry standards and guidelines. -
Integrated Ecosystem
Leveraging comprehensive expertise to support every phase of your trial. -
Enhanced Capabilities
Our Frederick, MD and Berlin, Germany location enhancements improve our ability to manage intricate trial demands.
Explore How We Deliver Smarter Kitting
Discover how our tailored kitting solutions support complex clinical trials. Take a look at both a quick overview of our global capabilities and an in-depth case study on how Precision kitting enabled a cell therapy trial with complex requirements.
Explore more Resources
Kitting development and supply management
- Trial and visit specific
- Multiple sample types
- Traceability of each component and expiry dates via 21CFR Part 11 compliant LIMS
- Detailed kit status reporting
- Sample collection training
Clinical site training
- Collection-specific quality assurance plans
- Development of training documentation
- Competency and monitoring programs
Logistics and transport management
- Export/import permits
- Late/evening shifts to receive deliveries and resolve shipment issues
- Knowledge in planning best path for shipment
- Ambient, refrigerated, or frozen shipment options
- Experience with all major couriers—eg, QuickStat, World Courier, FedEx, Marken
Explore Precision’s other clinical logistics services
-
Explore
PBMC & Sample Processing
Sample processing with expertise in PBMC isolations from labs across 5 continents
PBMC & Sample Processing
Sample processing with expertise in PBMC isolations from labs across 5 continents
-
Explore
Biostorage
Sample storage under all conditions and temperatures, rapid sample accessioning, and online inventory access
Biostorage
Sample storage under all conditions and temperatures, rapid sample accessioning, and online inventory access
-
Explore
Precision Lab e-Portal
Real-time visibility into project, sample, kit, and shipment status provides 24/7 access to critical study data
Precision Lab e-Portal
Real-time visibility into project, sample, kit, and shipment status provides 24/7 access to critical study data
Explore the Precision blog
Read our blog to gain more insights and discover work that Precision has supported.
Case Study: Delivering an Early-Phase Autoimmune Trial Across Regions
Early‑Phase Autoimmune Drug Development: Trial Design, Biomarkers and Statistical Strategies
has not third author: true, (SizeLimitingPyMap: {main={hs_id=213698206365, hs_child_table_id=0, hs_updated_at=1780680681226, hs_published_at=1780680684943, description=Rui F. Duarte‑Lopes is a senior biostatistics leader with over 31 years of international experience across biopharmaceutical, biotechnology, and CRO sectors. He provides strategic statistical oversight, ensuring rigorous, high‑quality, and decision‑focused delivery aligned with sponsor and regulatory expectations. He has more than 12 years of CRO experience supporting Phase I–IV clinical trials and has held roles including Lead Statistician, Project Lead, and Senior Manager. His therapeutic experience includes oncology and autoimmune diseases, notably lupus erythematosus, Crohn's disease and rheumatoid arthritis. Specializing in oncology over the past six years, Rui focuses on advanced solid tumors and early‑phase studies, contributing to study design, interim analyses, and data‑driven decision frameworks., avatar=Image{width=1200,height=1200,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Rui%20F%20Duarte-Lopes.jpg',altText='Rui F Duarte-Lopes',fileId=213695319705}, lastname=Duarte-Lopes, hs_initial_published_at=1779886328878, hs_created_by_user_id=26433386, hs_created_at=1779886165792, hs_is_edited=false, hs_deleted_at=0, name=Rui F, job=Senior Manager, Biostatistics, slug=rui-f-duarte-lopes, hs_updated_by_user_id=26433386}, second={}, third={}})
Case Study: Advancing IHC Assays from RUO to Clinical Trials and CDx
has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778874, hs_child_table_id=0, hs_updated_at=1765824406763, hs_published_at=1780680684943, description=Kennon Daniels is a scientific and regulatory in vitro diagnostic authority, specializing in the development of US regulatory strategies and FDA marketing submissions for IVD assays and instruments. Her expertise spans all aspects of product development, analytical and clinical trial protocol designs, Q-Submissions, IDEs, de novos, 510(k)s, and pre-market approval platforms., avatar=Image{width=576,height=576,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Kennon%20Daniels.webp',altText='Kennon Daniels',fileId=165893120790}, linkedin=https://www.linkedin.com/in/kennon-daniels-ph-d-84a90b6, hs_name=, hs_path=, lastname=Daniels, PhD, hs_initial_published_at=1775839468505, hs_created_at=1709645745105, hs_is_edited=false, hs_deleted_at=0, name=Kennon, position=Vice President, IVD Regulatory Consulting, job=, slug=kennon-daniels, email=, hs_updated_by_user_id=26433386}, second={hs_id=164426546714, hs_child_table_id=0, hs_updated_at=1778171432595, hs_published_at=1780680684943, description=Angélique Heckmann, PhD is a people‑driven leader who combines scientific expertise and business acumen with a strong foundation in human values. With a background in therapeutic drug development and an MBA‑shaped strategic mindset, she focuses on building meaningful, long‑term relationships with teams, partners, and clients. By bridging science and strategy, she supports informed decision‑making, fosters collaboration, and helps translate innovation into real‑world impact—always guided by a shared purpose: advancing solutions that ultimately improve patients’ lives, avatar=Image{width=287,height=287,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/PfMxMarkentive/authors/angelique-1.png',altText='angelique-1',fileId=194126030110}, lastname=Heckmann, PhD, hs_initial_published_at=1713174153602, hs_created_by_user_id=62155952, hs_created_at=1713172107894, hs_is_edited=false, hs_deleted_at=0, name=Angelique, job=Regional Vice President, Translational Business Solutions, slug=angelique-heckmann, hs_updated_by_user_id=26433386}, third={}})
